GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ontrak Inc (NAS:OTRK) » Definitions » COGS-to-Revenue

Ontrak (Ontrak) COGS-to-Revenue : 0.35 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Ontrak COGS-to-Revenue?

Ontrak's Cost of Goods Sold for the three months ended in Dec. 2023 was $1.25 Mil. Its Revenue for the three months ended in Dec. 2023 was $3.54 Mil.

Ontrak's COGS to Revenue for the three months ended in Dec. 2023 was 0.35.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Ontrak's Gross Margin % for the three months ended in Dec. 2023 was 64.62%.


Ontrak COGS-to-Revenue Historical Data

The historical data trend for Ontrak's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ontrak COGS-to-Revenue Chart

Ontrak Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.53 0.37 0.51 0.31

Ontrak Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.33 0.27 0.28 0.35

Ontrak COGS-to-Revenue Calculation

Ontrak's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3.943 / 12.743
=0.31

Ontrak's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.252 / 3.539
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ontrak  (NAS:OTRK) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Ontrak's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1.252 / 3.539
=64.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Ontrak COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ontrak's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ontrak (Ontrak) Business Description

Traded in Other Exchanges
Address
2200 Paseo Verde Parkway, Suite 280, Henderson, NV, USA, 89052
Ontrak Inc is an AI and telehealth-enabled, virtualized outpatient healthcare treatment company. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The company's technology-enabled platform provides claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized treatment program.
Executives
Judith Feld officer: Chief Medical Officer 2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James M. Messina director 2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
Arik Hill officer: Chief Information Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Robert Accordino officer: Chief Medical Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Mary Louise Osborne officer: Chief Customer Officer 2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James J Park officer: Chief Accounting Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Jonathan E. Mayhew officer: Chief Executive Officer ONE CVS DRIVE, WOONSOCKET RI 02895
Terren S Peizer director, 10 percent owner, officer: CEO 11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Robert I Newton officer: General Counsel and Secretary 1940 E. MARIPOSA AVE, ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
Katherine B Quinn director US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Robert Rebak director 2120 COLORADO BLVD., SUITE 230, SANTA MONICA CA 90404
Curtis Medeiros officer: Chief Operating Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Brandon H Laverne officer: Chief Financial Officer 1940 E. MARIPOSA AVE., ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
David E Smith 10 percent owner 888 LINDA FLORA DRIVE, LOS ANGELES CA 90049
Gustavo A Giraldo director 2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404